Heidi Health pricing

About

Heidi Health is an ambient AI clinical scribe: clinicians speak naturally during a patient encounter and Heidi produces a structured clinical note, handles transcription, and surfaces grounded clinical evidence with citations. Founded in Australia, the company targets doctors, nurses, mental-health and allied-health providers, dentists, and veterinarians, and reports deployment across 200+ specialties. Its core pitch is reclaiming documentation time — the marketing claims roughly 6 minutes saved per encounter and 90% less documentation work.

The product is sold as a per-seat SaaS with a genuine free-forever tier, positioning Heidi against other ambient-scribe and clinical-documentation vendors. Individual clinicians can self-serve up through the Clinician plan, while team, practice, and enterprise deployments route through sales (“Talk to us” / “Contact sales”). A separate product, Heidi Comms (an AI receptionist that answers, schedules, and resolves patient calls), is offered as a sales-led add-on rather than a self-serve SKU.

Heidi is privately held and Melbourne-based. It began as Oscer, an AI clinical-reasoning startup, before relaunching as Heidi’s ambient scribe in early 2024 (which is why its Crunchbase entity is still oscer). The company has raised roughly US$97M across rounds: an initial A$10M Series A (Nov 2023), a US$16.6M Series A extension led by Headline (Mar 2025, with Blackbird, Anthology/Menlo+Anthropic and others), and a US$65M Series B led by Point72 Private Investments — Steve Cohen’s firm — in October 2025 at a reported ~$465M valuation (TechCrunch). At the Series B, Heidi reported working with 2M+ clinicians weekly and processing 70M+ patient visits across 116 countries. Precise ARR and headcount are not disclosed.

Pricing summary : How Heidi Health’s per-seat freemium clinical-scribe pricing works

Heidi Health uses a per-seat subscription with a free tier (a freemium model), split across two audience tabs on the pricing page — “For Individuals” and “For Teams and Enterprise” — each priced in per-seat units:

1. Individual plans (self-serve): Free ($0), Evidence Plus ($30/user/mo), and Clinician ($110/user/mo, marked “Most Popular”). Paid individual prices shown are the yearly-billed rate; a Monthly toggle exists per card, with annual billing advertised as saving $120 (Evidence Plus) or $480 (Clinician) per year.
2. Team & Enterprise plans (sales-led): Evidence Team ($50/user/mo, billed annually), Practice ($180/user/mo, billed annually), and Enterprise (Custom, “flexible billing”). All three carry “Talk to us” CTAs.
3. Add-on: Heidi Comms, an AI receptionist for patient calls, is quoted “Talk to us” with no published unit price.

What makes this different: the free tier is unusually generous for clinical AI — unlimited AI documentation and unlimited cited clinical evidence at $0 — so paid upgrades sell on evidence depth, team controls, and governance rather than on unlocking core scribing.

Pricing by product

Heidi scribe (Individual plans)

Heidi scribe (Teams and Enterprise plans)

Heidi Comms (separate add-on product)

Sales motions across products: PLG / self-serve for Free, Evidence Plus and Clinician; sales-led for Evidence Team, Practice, Enterprise and the Heidi Comms add-on.

Hidden costs : What clinical teams actually pay beyond the headline seat price

Heidi’s seat price is unusually legible — there is no usage meter to blow a budget, since consults and documentation are unlimited at every tier. The real cost variance comes from which tier you actually need, the annual-vs-monthly delta, region/currency, and the sales-gated add-ons.

Representative annual bills (USD, per the June 2026 capture):

Where the headline price understates the bill:

• Annual-only framing. Paid prices are displayed as a per-month number but the headline rate is the yearly-billed one; the monthly toggle costs more. Annual billing is advertised as saving $120/yr (Evidence Plus) or $480/yr (Clinician), so the monthly path is materially pricier than the sticker implies.
• “Pro actions” / Scribe credits. Free and the entry Evidence tiers cap advanced agentic features (Ask Heidi prompts, custom template generation) at ~10 actions per month per Heidi’s help center. Heavy users of those features are effectively pushed to Clinician/Practice for “unlimited.”
• EHR integration is an add-on. The plan-comparison matrix lists “EHR integration add-on” as a separate line on Practice/Enterprise — integration into your record system is not bundled into the seat price.
• Heidi Comms is uncosted. The AI receptionist add-on is “Talk to us” with no public unit price, so any front-desk automation is a separate, sales-negotiated line.
• Region/currency. Prices vary by currency selector and geo; third-party trackers report a US/en-us Clinician rate higher than the $110 we captured on the default surface — confirm your own region’s page before budgeting.

For the mechanics of capping advanced features behind action limits, see our guide to entitlements and usage grants and our write-up on why per-user AI licenses are under pressure.

Want to estimate your own Heidi Health bill? Use the Heidi Health pricing calculator to model your monthly cost based on plan tier and seat count.

Pricing evolution : From free clinical scribe toward tiered team and enterprise plans

Heidi has rebuilt its pricing three times in roughly two years, and the trajectory is one of the cleaner case studies in the corpus: paid-only → freemium → multi-tier USD → evidence-centric repackaging. Crucially, the value metric never moved — it has always been per-clinician — but the packaging, currency, and upsell story changed repeatedly.

Cadence

Tracked range: 2024-01-17 – 2026-06-05, from Wayback snapshots of heidihealth.com/pricing.

Notable changes

• 2024-01 — Paid-only: Clinician $199/mo ($1,799/yr), per-FTE clinic option. No free tier (Wayback).
• 2024-02 — Freemium pivot: Free-forever scribe + Heidi Pro at $69 USD/mo (Wayback).
• 2024-04 — AUD pricing with a third tier: Pro $99 AUD/mo, Clinic $149 AUD/mo (Wayback).
• 2024-11 — Four-tier USD annual ladder: Free / Pro $799 / Together $1,199 / Enterprise, plus a ‘Pro actions’ quota (Wayback).
• 2025-09 — Pro $799 / Together $1,199 confirmed stable (Wayback).
• 2025-11 — Evidence-centric tier names (‘Practice’, ‘Clinician’) overtake ‘Together’ on the page (Wayback); the repackaging followed Heidi’s October 2025 Series B.
• 2026-06 — Current per-seat ladder: Free / Evidence Plus $30 / Clinician $110 (individuals); Evidence Team $50 / Practice $180 / Enterprise Custom (teams).

For more on how SaaS companies migrate packaging without breaking existing customers, see usage-based pricing migration for SaaS.

What’s unique : Distinctive mechanics in Heidi’s clinical-scribe pricing

Three things make Heidi’s pricing distinctive against both horizontal SaaS and other clinical-AI vendors:

1. The free tier gives away the core job-to-be-done. Most freemium products gate the main value behind a paywall and let you taste it for free. Heidi inverts this: unlimited AI documentation and unlimited cited clinical evidence are free forever. Paid tiers don’t unlock scribing — they unlock evidence depth, team controls, and governance. This is a deliberate land-grab in a market where competitors charge “hefty prices for transcription,” in Heidi’s own 2024 words.

2. The value metric is the clinician, not the work. Heidi has never metered consults, minutes, or tokens — every tier advertises “unlimited.” It charges strictly per seat / per FTE. That makes bills predictable for buyers but caps Heidi’s upside on its heaviest users, the opposite of usage-based models where revenue scales with consumption. The choice of value metric here is a strategic bet on adoption over extraction.

3. The upsell story was re-pointed from features to evidence. The 2024 “Pro/Together” ladder sold features (custom templates, priority processing). The late-2025 “Evidence Plus / Clinician / Evidence Team / Practice” ladder sells clinical-evidence depth (premium sources, live in-visit suggestions, personal/team evidence libraries). Same per-seat mechanic, but the differentiator moved up-market into clinical decision support — a more defensible moat than template management.

Strengths & weaknesses

Strengths

• Genuinely usable free tier. Unlimited notes and cited evidence at $0 makes Heidi the default “try it risk-free” recommendation in clinician communities — on Reddit’s r/FamilyMedicine and r/medicine it is frequently named as the budget/free pick, and a geriatrics physician described it as “a game changer.” That word-of-mouth is a cheap acquisition engine.
• Predictable, legible bills. Per-seat pricing with unlimited usage means no bill-shock — a meaningful advantage in healthcare procurement, where finance teams distrust variable AI costs.
• Clear upgrade ladder. Free → Evidence Plus → Clinician → (Evidence Team → Practice → Enterprise) maps cleanly from solo evaluation to multi-site governance, with the audience tab split keeping the self-serve and sales-led journeys separate.

Weaknesses

• Reliability is now the headline complaint. By May 2026, Heidi’s Trustpilot score had fallen to 3.3/5 across 481 reviews, with recent 1-star reviews dominated by lost recordings and dropped patient sessions (“losing between 3 and 6 sessions every week”). For a paid clinical tool, lost transcripts are an existential trust problem that no pricing tier fixes.
• Data-privacy questions. Threads on r/GPUK and r/doctorsUK pair note-quality praise with recurring questions about data handling — a friction point Heidi’s pricing/trust pages must continually answer.
• Opaque enterprise and add-on pricing. Practice’s true cost (EHR-integration add-on), Enterprise (Custom), and Heidi Comms (“Talk to us”) are all sales-gated, so the published ladder understates the real cost for the buyers with the most budget.
• Geo/currency ambiguity. The per-month display of an annually-billed price, plus region-varying currency (third-party trackers report a higher US Clinician rate than the $110 we captured), makes cross-market comparison harder than it should be.

Billing UX : Currency, billing-period and audience controls on the pricing page

• For Individuals / For Teams and Enterprise audience toggle — a segmented control at the top of the pricing page swaps the entire plan set between the three individual tiers and the three team/enterprise tiers.
• Currency selector — an explicit currency dropdown (showing USD ($) in this capture) lets users switch the displayed currency; the site also geo-detects currency via a preferred-currency cookie.
• Per-card Billed Yearly / Monthly toggle — each paid individual plan card has a Yearly/Monthly switch; Yearly is the default and surfaces the savings (e.g. “Save $120”, “Save $480”).
• “Try 14 days free” trial CTA — paid plans expose a 14-day free trial alongside a “Talk to us” sales path.
• Compare our plans matrix — a full feature-comparison table (Scribe / Evidence / Platform rows) sits below the cards, also tab-split by Individuals vs Teams & Enterprise.

Strategic wins : Pricing decisions that are working for Heidi

1. Free-forever core as a growth flywheel

Giving away unlimited scribing turned Heidi into the default community recommendation and helped it reach 2M+ clinicians weekly and 70M+ patient visits by the 2025 Series B. Co-founder Dr. Tom Kelly has publicly credited the freemium approach for customer acquisition. In a market where rivals charge for transcription, free core scribing is a wedge, not a giveaway.

2. Moving the upsell into clinical evidence

The late-2025 repackaging shifted paid differentiation from generic features to clinical-evidence depth (premium sources, live in-visit suggestions, evidence libraries). That ties the upgrade to clinicians’ actual decision-making, a stickier and more defensible reason to pay than template management — and aligns the paid story with the company’s “AI care partner” positioning at Series B.

3. Clean self-serve vs sales-led split

The “For Individuals / For Teams and Enterprise” tab cleanly separates a PLG motion (Free → Evidence Plus → Clinician, all self-serve with 14-day trials) from a sales-led motion (Evidence Team, Practice, Enterprise, Heidi Comms). Individuals can adopt without talking to anyone; organizations get routed to a quote. See our note on why per-user AI licenses are evolving for the broader context.

Areas to improve : Gaps in Heidi’s pricing presentation

1. Reconcile the per-month display with annual-only billing

Showing an annually-billed rate as a per-month figure, with the cheaper monthly toggle actually costing more, is easy to misread. A clearer “$X/user/mo billed annually (or $Y month-to-month)” framing per card would reduce surprise at checkout.

2. Publish a price for at least one team tier without sales

Three of six tiers (Evidence Team, Practice in practice, Enterprise) carry “Talk to us.” Practices comparing scribes have to enter a sales cycle just to learn a number. Even an indicative per-seat band for Evidence Team / Practice would lower friction for the SMB segment Heidi clearly wants.

3. Make region/currency unambiguous

With the US en-us page reportedly showing a higher Clinician rate than the default surface, buyers can’t trust a single quoted number. A visible “prices shown for your region” label and a transparent currency note would prevent cross-market confusion.

4. Address the reliability narrative on the pricing/trust surface

When the loudest recent reviews are about lost sessions, a pricing page that leans on “100s of 5-star testimonials” reads as out of step. Surfacing uptime/SLA commitments (currently buried in the comparison matrix) earlier would better answer the question paying clinicians are actually asking.

Key takeaways

1. Heidi is per-seat freemium, not usage-based. Free-forever core scribing, then paid tiers at $30 (Evidence Plus) and $110 (Clinician) per user/month for individuals, and $50 (Evidence Team) / $180 (Practice) / Custom (Enterprise) for teams — all per clinician, all “unlimited usage.”
2. The free tier is the strategy. Unlimited documentation and cited evidence at $0 drives community-led adoption; paid upgrades sell evidence depth and governance, not core function.
3. Pricing has been rebuilt three times since 2024 — paid-only → freemium → USD multi-tier → evidence-centric — while the per-clinician value metric never changed.
4. Funding is no longer the constraint. ~US$97M raised, a US$65M Point72-led Series B (Oct 2025) at a ~$465M valuation, and 2M+ weekly clinicians give Heidi room to keep core scribing free.
5. Reliability is the open risk. A 3.3/5 Trustpilot (481 reviews, May 2026) with recurring lost-session complaints is the trust gap that the generous pricing can’t paper over.

UBP implications

1. Freemium can win a category before monetization is solved. Heidi made the expensive core function free, captured massive top-of-funnel, and only then figured out what to charge for. For AI products weighing usage vs subscription, Heidi is a case for prioritizing adoption metrics over early ARPU.
2. Per-seat “unlimited” is a deliberate margin trade. By refusing to meter consults or tokens, Heidi accepts capped revenue on power users in exchange for predictable bills and zero bill-shock — a viable counter-position to the consumption-pricing wave, especially in budget-sensitive verticals like healthcare. Compare the usage-metric selection trade-offs.
3. Repackaging can re-point an upsell without touching the meter. Heidi moved its paid differentiator from features to clinical-evidence depth without changing the per-seat unit — a reminder that packaging and value metric are separable levers. See understanding usage-based pricing models for the framework.

Sources

• Heidi Health pricing page (accessed 2026-06-05)
• Heidi Health enterprise page (accessed 2026-06-05)
• Heidi help center — pricing plans, cost and features (accessed 2026-06-06)
• Heidi pricing page — Wayback archive (Jan 2024 – Sep 2025) (accessed 2026-06-06)

Browse the full pricing blueprint for more clinical-AI comparisons.

Bottom line

Heidi Health is one of the cleanest freemium plays in clinical AI: give away unlimited ambient scribing and cited evidence, charge per clinician for depth and governance, and let community adoption do the selling. The strategy has worked — 2M+ weekly clinicians, 70M+ visits, and a US$65M Point72-led Series B at a ~$465M valuation. The pricing itself has been rebuilt three times since 2024 (paid-only → freemium → USD multi-tier → evidence-centric) while the per-seat value metric stayed constant, making Heidi a useful study in separating packaging from the meter. The watch-item isn’t price; it’s reliability — a 3.3/5 Trustpilot and recurring lost-session reports are the kind of trust gap that generous free tiers can mask but not cure.

Pricing timeline : Major events on a vertical axis

Each milestone below corresponds to a public pricing change, product launch, or material adjustment. Major events use a filled marker; minor adjustments use a faded one.

Current: per-seat Evidence/Clinician/Practice tiers (monthly-displayed)

Jun 2026

Captured live: Individuals — Free ($0), Evidence Plus ($30/user/mo), Clinician ($110/user/mo, Most Popular). Teams & Enterprise — Evidence Team ($50/user/mo), Practice ($180/user/mo), Enterprise (Custom). Prices shown billed yearly, displayed per-month, in USD; currency varies by region (a US/en-us geo reportedly shows higher Clinician pricing, unverified in our capture). Heidi Comms AI receptionist is a separate Talk-to-us add-on.

Evidence-centric repackaging begins (post-Series B)

Nov 2025

Wayback (20251104180725) shows the tier names transitioning: 'Practice' and 'Clinician' now dominate the page while 'Together' fades to a legacy reference. The rebuild of tiers around clinical-evidence depth rolled out in Q4 2025, alongside the Oct 2025 Series B.

Pro $799 / Together $1,199 holds steady through Q3 2025

Sep 2025

Wayback (20250909223525) confirms the same USD annual prices persisted: Free, Pro $799, Together $1,199, Enterprise (Custom). Pricing was stable from ~Nov 2024 to ~Sep 2025; 14-day trials replaced the earlier 7/30-day trials.

Repackaged to USD annual — Free / Pro $799 / Together $1,199 / Enterprise

Nov 2024

Wayback (20241109201703) shows a four-tier USD ladder billed annually: Free ($0), Pro ($799 USD/yr, individuals), Together ($1,199 USD/user/yr, teams, 'Most popular'), and Enterprise (Custom). Introduced the 'Pro actions' metering concept (10/mo on Free) and a full feature-comparison matrix. '50+ countries.'

Three tiers in AUD — Basic / Pro $99 AUD / Clinic $149 AUD

Apr 2024

Wayback (20240419174608) shows AUD pricing with a third tier: Basic (Free), Pro 'starting at $99 AUD/mo', and Clinic 'starting at $149 AUD/mo' (EHR integrations, billing recommendations, multi-clinician). Clinic billed per-FTE via annual contract. 'Trusted in 35+ countries.'

Freemium pivot — Free forever + Heidi Pro at $69/mo

Feb 2024

Wayback (20240212223056) shows the model flipped to freemium: 'Heidi Free forever' (unlimited notes, custom templates, 10 AI prompts) plus 'Heidi Pro' at $69 USD/mo with a 7-day free trial. Core note generation became free; Pro sold unlimited dictation and priority processing.

Paid-only: Clinician license at $199/month, no free tier

Jan 2024

Wayback (web.archive.org/web/20240117044058) shows Heidi as a paid-only product: Clinician Monthly $199/mo ($7/day), Clinician Yearly $1,799/yr ($5/day, 'Save ~$600'), and a per-FTE 'Multiple Clinicians' clinic option. No free plan existed. Banner read 'Today is an important day.'